A Caltech Library Service

Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike

Scharf, Louise and Scheid, Johannes F. and Lee, Jeong-Hyun and West, Anthony P., Jr. and Chen, Courtney and Gao, Han and Gnanapragasam, Priyanthi N. P. and Mares, René and Seaman, Michael S. and Ward, Andrew B. and Nussenzweig, Michel C. and Bjorkman, Pamela J. (2014) Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike. Cell Reports, 7 (3). pp. 785-795. ISSN 2211-1247. PMCID PMC4109818.

PDF - Published Version
Creative Commons Attribution Non-commercial No Derivatives.

PDF (Document S1. Supplemental Experimental Procedures, Figures S1–S7, and Tables S1–S4) - Supplemental Material
Creative Commons Attribution Non-commercial No Derivatives.

[img] MS Excel (Table S5. Neutralization Activity of Bulk-Sorted Clonal Members of 8ANC195, Related to Figure 6) - Supplemental Material
Creative Commons Attribution Non-commercial No Derivatives.


Use this Persistent URL to link to this item:


Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection in animal models. Characterized bNAb targets, although key to vaccine and therapeutic strategies, are currently limited. We defined a new site of vulnerability by solving structures of bNAb 8ANC195 complexed with monomeric gp120 by X-ray crystallography and trimeric Env by electron microscopy. The site includes portions of gp41 and N-linked glycans adjacent to the CD4-binding site on gp120, making 8ANC195 the first donor-derived anti-HIV-1 bNAb with an epitope spanning both Env subunits. Rather than penetrating the glycan shield by using a single variable-region CDR loop, 8ANC195 inserted its entire heavy-chain variable domain into a gap to form a large interface with gp120 glycans and regions of the gp120 inner domain not contacted by other bNAbs. By isolating additional 8ANC195 clonal variants, we identified a more potent variant, which may be valuable for therapeutic approaches using bNAb combinations with nonoverlapping epitopes.

Item Type:Article
Related URLs:
URLURL TypeDescription CentralArticle
Nussenzweig, Michel C.0000-0003-0592-8564
Bjorkman, Pamela J.0000-0002-2277-3990
Additional Information:© 2014 The Authors. This is an open access article under the CC BY-NC-ND license ( Available online 24 April 2014. Received: March 4, 2014. Revised: April 1, 2014. Accepted: April 4, 2014. Published: April 24, 2014. This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Grants HIVRAD P01 AI100148 (to P.J.B. and M.C.N.) and HIVRAD P01 AI082362 (to A.B.W.) (the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health); the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Grants 1040753 [to P.J.B.] and 38619s [to M.C.N.] and Comprehensive Antibody-Vaccine Immune Monitoring Consortium Grant 1032144 [to M.S.S.]); NIH Center for HIV/AID Vaccine Immunology and Immunogen Discovery 1UM1 AI100663-01 (to M.C.N.); American Cancer Society Grant PF-13-076-01-MPC (to L.S.); a Dissertation Fellowship from the California HIV/AIDS Research Program (to JH.L); and the Molecular Observatory at Caltech supported by the Gordon and Betty Moore Foundation. The EM work was conducted at the National Resource for Automated Molecular Microscopy at The Scripps Research Institute, which is supported by the Biomedical Technology Research Center program (GM103310) of the National Institute of General Medical Sciences. We thank John P. Moore and Albert Cupo (Weill Cornell Medical College) for purified SOSIP trimers, Anna Gazumyan and Cassie Liu (Rockefeller University) for help with antibody expression, Brittany Lewis (Cornell Medical School) for help with cloning of 8ANC195 variants, and the Caltech Protein Expression Center for producing antibody and gp120 proteins, generation of suspension-adapted HEK293-S cells, and use of the Biacore T100. Operations at the Stanford Synchrotron Radiation Lightsource are supported by the US Department of Energy and the National Institutes of Health. We thank the beamline staff at the Advanced Photon Source GM/CA-CAT for use and support for beamline 23ID-D. M.C.N. and P.J.B. are Howard Hughes Medical Institute Investigators.
Funding AgencyGrant Number
AIDS Vaccine Discovery Grants1040753
AIDS Vaccine Discovery Grants38619s
Comprehensive Antibody-Vaccine Immune Monitoring Consortium1032144
NIH1UM1 AI100663-01
American Cancer SocietyPF-13-076-01-MPC
Gordon and Betty Moore FoundationUNSPECIFIED
Department of Energy (DOE)UNSPECIFIED
Howard Hughes Medical Institute (HHMI)UNSPECIFIED
Issue or Number:3
PubMed Central ID:PMC4109818
Record Number:CaltechAUTHORS:20140505-103212905
Persistent URL:
Official Citation:Louise Scharf, Johannes F. Scheid, Jeong Hyun Lee, Anthony P. West Jr., Courtney Chen, Han Gao, Priyanthi N.P. Gnanapragasam, René Mares, Michael S. Seaman, Andrew B. Ward, Michel C. Nussenzweig, Pamela J. Bjorkman, Spike, Cell Reports, Volume 7, Issue 3, 8 May 2014, Pages 785-795, ISSN 2211-1247, (
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:45493
Deposited By: Ruth Sustaita
Deposited On:05 May 2014 20:17
Last Modified:03 Oct 2019 06:31

Repository Staff Only: item control page